Osteoarthritis Pain Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drugs (NSAIDs, Analgesics, Viscosupplements, Corticosteroids, Others); Route of Administration (Oral, Parenteral, Topical); Dosage Form (Solid, Liquid, Semi-solid); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Report Code: TIPRE00020947 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Osteoarthritis may experience signs and symptoms that can include joint-specific pain at rest or while walking/climbing stairs, pain at night, soreness to the touch of the affected joints, decreased range of motion, etc. Osteoarthritis pain drugs help to relieve the pain that occurs when a person suffers from OA.The osteoarthritis pain drugs market is segmented based on drug class, the route of administration, and dosage form.

MARKET DYNAMICS

The osteoarthritis pain drugs market is driving by factors such as osteoarthritis (OA), the most prevalent form of joint disease, affects 28 million people in the US and an estimated 4-13% of the world's population. It is the most common cause of disability in people over age 65. World Health Organization also states that worldwide estimates for Osteoarthritis report that 9.6% of men and 18.0% of women. This high prevalence creates a need for Osteoarthritis pain drugs. However, the side effects of the drugs and loss of patent exclusivity of branded therapies may confine the growth of the market.

MARKET SCOPE

The "Osteoarthritis Pain Drugs Market to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Osteoarthritis Pain Drugs Market with detailed market segmentation by product types and end user. The Osteoarthritis Pain Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Osteoarthritis Pain Drugs Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The osteoarthritis pain drugs market is segmented on the basis of drugs, route of administration, dosage form, and distribution channel. Based on drugs, the market is segmented as NSAIDs, analgesics, viscosupplements, corticosteroids, others. Based on route of administration, the market is segmented as oral, parenteral, topical. Based on dosage form, the market is segmented as solid, liquid, semi-solid. Based on distribution channel, the market is segmented as hospital pharmacies, retail pharmacies and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Osteoarthritis Pain Drugs Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Osteoarthritis Pain Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Osteoarthritis Pain Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Osteoarthritis Pain Drugs Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Osteoarthritis Pain Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Osteoarthritis Pain Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Osteoarthritis Pain Drugs Market in the global market. Below mentioned is the list of few companies engaged in the Inositol Market.

The report also includes the profiles of key players in osteoarthritis pain drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Sanofi
  •   Horizon Therapeutics PLC
  •   Johnson & Johnson
  •   GlaxoSmithKline PLC
  •   Bayer AG
  •   Abbott
  •   Pfizer, Inc.
  •   Eli Lilly
  •   Anika Therapeutics, Inc.
  •   Novartis AG

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Osteoarthritis Pain Drugs Market - By Drugs
1.3.2 Osteoarthritis Pain Drugs Market - By Route of Administration
1.3.3 Osteoarthritis Pain Drugs Market - By Dosage Form
1.3.4 Osteoarthritis Pain Drugs Market - By Distribution Channel
1.3.5 Osteoarthritis Pain Drugs Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OSTEOARTHRITIS PAIN DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OSTEOARTHRITIS PAIN DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OSTEOARTHRITIS PAIN DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. OSTEOARTHRITIS PAIN DRUGS - GLOBAL MARKET OVERVIEW
6.2. OSTEOARTHRITIS PAIN DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. OSTEOARTHRITIS PAIN DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUGS
7.1. OVERVIEW
7.2. DRUGS MARKET FORECASTS AND ANALYSIS
7.3. NSAIDS
7.3.1. Overview
7.3.2. NSAIDs Market Forecast and Analysis
7.4. ANALGESICS
7.4.1. Overview
7.4.2. Analgesics Market Forecast and Analysis
7.5. VISCOSUPPLEMENTS
7.5.1. Overview
7.5.2. Viscosupplements Market Forecast and Analysis
7.6. CORTICOSTEROIDS
7.6.1. Overview
7.6.2. Corticosteroids Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. OSTEOARTHRITIS PAIN DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
8.5. TOPICAL
8.5.1. Overview
8.5.2. Topical Market Forecast and Analysis
9. OSTEOARTHRITIS PAIN DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE FORM
9.1. OVERVIEW
9.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
9.3. SOLID
9.3.1. Overview
9.3.2. Solid Market Forecast and Analysis
9.4. LIQUID
9.4.1. Overview
9.4.2. Liquid Market Forecast and Analysis
9.5. SEMI-SOLID
9.5.1. Overview
9.5.2. Semi-solid Market Forecast and Analysis
10. OSTEOARTHRITIS PAIN DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis
11. OSTEOARTHRITIS PAIN DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Osteoarthritis Pain Drugs Market Overview
11.1.2 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.1.3 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.1.4 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.1.6 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.1.7.1 United States Osteoarthritis Pain Drugs Market
11.1.7.1.1 United States Osteoarthritis Pain Drugs Market by Drugs
11.1.7.1.2 United States Osteoarthritis Pain Drugs Market by Route of Administration
11.1.7.1.3 United States Osteoarthritis Pain Drugs Market by Dosage Form
11.1.7.1.4 United States Osteoarthritis Pain Drugs Market by Distribution Channel
11.1.7.2 Canada Osteoarthritis Pain Drugs Market
11.1.7.2.1 Canada Osteoarthritis Pain Drugs Market by Drugs
11.1.7.2.2 Canada Osteoarthritis Pain Drugs Market by Route of Administration
11.1.7.2.3 Canada Osteoarthritis Pain Drugs Market by Dosage Form
11.1.7.2.4 Canada Osteoarthritis Pain Drugs Market by Distribution Channel
11.1.7.3 Mexico Osteoarthritis Pain Drugs Market
11.1.7.3.1 Mexico Osteoarthritis Pain Drugs Market by Drugs
11.1.7.3.2 Mexico Osteoarthritis Pain Drugs Market by Route of Administration
11.1.7.3.3 Mexico Osteoarthritis Pain Drugs Market by Dosage Form
11.1.7.3.4 Mexico Osteoarthritis Pain Drugs Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Osteoarthritis Pain Drugs Market Overview
11.2.2 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.2.3 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.2.4 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.2.6 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Osteoarthritis Pain Drugs Market
11.2.7.1.1 Germany Osteoarthritis Pain Drugs Market by Drugs
11.2.7.1.2 Germany Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.1.3 Germany Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.1.4 Germany Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.2 France Osteoarthritis Pain Drugs Market
11.2.7.2.1 France Osteoarthritis Pain Drugs Market by Drugs
11.2.7.2.2 France Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.2.3 France Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.2.4 France Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.3 Italy Osteoarthritis Pain Drugs Market
11.2.7.3.1 Italy Osteoarthritis Pain Drugs Market by Drugs
11.2.7.3.2 Italy Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.3.3 Italy Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.3.4 Italy Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.4 Spain Osteoarthritis Pain Drugs Market
11.2.7.4.1 Spain Osteoarthritis Pain Drugs Market by Drugs
11.2.7.4.2 Spain Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.4.3 Spain Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.4.4 Spain Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.5 United Kingdom Osteoarthritis Pain Drugs Market
11.2.7.5.1 United Kingdom Osteoarthritis Pain Drugs Market by Drugs
11.2.7.5.2 United Kingdom Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.5.3 United Kingdom Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.5.4 United Kingdom Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.6 Rest of Europe Osteoarthritis Pain Drugs Market
11.2.7.6.1 Rest of Europe Osteoarthritis Pain Drugs Market by Drugs
11.2.7.6.2 Rest of Europe Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.6.3 Rest of Europe Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.6.4 Rest of Europe Osteoarthritis Pain Drugs Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Osteoarthritis Pain Drugs Market Overview
11.3.2 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.3.3 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.3.4 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.3.6 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Osteoarthritis Pain Drugs Market
11.3.7.1.1 Australia Osteoarthritis Pain Drugs Market by Drugs
11.3.7.1.2 Australia Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.1.3 Australia Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.1.4 Australia Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.2 China Osteoarthritis Pain Drugs Market
11.3.7.2.1 China Osteoarthritis Pain Drugs Market by Drugs
11.3.7.2.2 China Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.2.3 China Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.2.4 China Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.3 India Osteoarthritis Pain Drugs Market
11.3.7.3.1 India Osteoarthritis Pain Drugs Market by Drugs
11.3.7.3.2 India Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.3.3 India Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.3.4 India Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.4 Japan Osteoarthritis Pain Drugs Market
11.3.7.4.1 Japan Osteoarthritis Pain Drugs Market by Drugs
11.3.7.4.2 Japan Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.4.3 Japan Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.4.4 Japan Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.5 South Korea Osteoarthritis Pain Drugs Market
11.3.7.5.1 South Korea Osteoarthritis Pain Drugs Market by Drugs
11.3.7.5.2 South Korea Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.5.3 South Korea Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.5.4 South Korea Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market
11.3.7.6.1 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market by Drugs
11.3.7.6.2 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.6.3 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.6.4 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Osteoarthritis Pain Drugs Market Overview
11.4.2 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.4.3 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.4.4 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.4.6 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Osteoarthritis Pain Drugs Market
11.4.7.1.1 South Africa Osteoarthritis Pain Drugs Market by Drugs
11.4.7.1.2 South Africa Osteoarthritis Pain Drugs Market by Route of Administration
11.4.7.1.3 South Africa Osteoarthritis Pain Drugs Market by Dosage Form
11.4.7.1.4 South Africa Osteoarthritis Pain Drugs Market by Distribution Channel
11.4.7.2 Saudi Arabia Osteoarthritis Pain Drugs Market
11.4.7.2.1 Saudi Arabia Osteoarthritis Pain Drugs Market by Drugs
11.4.7.2.2 Saudi Arabia Osteoarthritis Pain Drugs Market by Route of Administration
11.4.7.2.3 Saudi Arabia Osteoarthritis Pain Drugs Market by Dosage Form
11.4.7.2.4 Saudi Arabia Osteoarthritis Pain Drugs Market by Distribution Channel
11.4.7.3 U.A.E Osteoarthritis Pain Drugs Market
11.4.7.3.1 U.A.E Osteoarthritis Pain Drugs Market by Drugs
11.4.7.3.2 U.A.E Osteoarthritis Pain Drugs Market by Route of Administration
11.4.7.3.3 U.A.E Osteoarthritis Pain Drugs Market by Dosage Form
11.4.7.3.4 U.A.E Osteoarthritis Pain Drugs Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market
11.4.7.4.1 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market by Drugs
11.4.7.4.2 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market by Route of Administration
11.4.7.4.3 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market by Dosage Form
11.4.7.4.4 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Osteoarthritis Pain Drugs Market Overview
11.5.2 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.5.3 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.5.4 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.5.6 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Osteoarthritis Pain Drugs Market
11.5.7.1.1 Brazil Osteoarthritis Pain Drugs Market by Drugs
11.5.7.1.2 Brazil Osteoarthritis Pain Drugs Market by Route of Administration
11.5.7.1.3 Brazil Osteoarthritis Pain Drugs Market by Dosage Form
11.5.7.1.4 Brazil Osteoarthritis Pain Drugs Market by Distribution Channel
11.5.7.2 Argentina Osteoarthritis Pain Drugs Market
11.5.7.2.1 Argentina Osteoarthritis Pain Drugs Market by Drugs
11.5.7.2.2 Argentina Osteoarthritis Pain Drugs Market by Route of Administration
11.5.7.2.3 Argentina Osteoarthritis Pain Drugs Market by Dosage Form
11.5.7.2.4 Argentina Osteoarthritis Pain Drugs Market by Distribution Channel
11.5.7.3 Rest of South and Central America Osteoarthritis Pain Drugs Market
11.5.7.3.1 Rest of South and Central America Osteoarthritis Pain Drugs Market by Drugs
11.5.7.3.2 Rest of South and Central America Osteoarthritis Pain Drugs Market by Route of Administration
11.5.7.3.3 Rest of South and Central America Osteoarthritis Pain Drugs Market by Dosage Form
11.5.7.3.4 Rest of South and Central America Osteoarthritis Pain Drugs Market by Distribution Channel
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL OSTEOARTHRITIS PAIN DRUGS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. OSTEOARTHRITIS PAIN DRUGS MARKET, KEY COMPANY PROFILES
14.1. SANOFI
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. HORIZON THERAPEUTICS PLC
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. JOHNSON AND JOHNSON
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. GLAXOSMITHKLINE PLC
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BAYER AG
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. ABBOTT
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. PFIZER, INC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ELI LILLY
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ANIKA THERAPEUTICS, INC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. NOVARTIS AG
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Sanofi
2. Horizon Therapeutics PLC
3. Johnson & Johnson
4. GlaxoSmithKline PLC
5. Bayer AG
6. Abbott
7. Pfizer, Inc.
8. Eli Lilly
9. Anika Therapeutics, Inc.
10. Novartis AG
11. Ferring Pharmaceuticals
12. Bioventus
13. Zimmer Biomet Holdings, Inc.
14. Fidia Farmaceutici s.p.a.
15. Flexion Therapeutics, Inc.
TIPRE00020947
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking